Activity of anthracycline- and ifosfamide-based chemotherapy in a series of patients affected by advanced myxofibrosarcoma.

about

Activity of anthracycline- and ifosfamide-based chemotherapy in a series of patients affected by advanced myxofibrosarcoma.

Item

http://www.wikidata.org/entity/Q41501364

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Activity of anthracycline- and ...... by advanced myxofibrosarcoma.

@en

type

Item

label

Activity of anthracycline- and ...... by advanced myxofibrosarcoma.

@en

prefLabel

Activity of anthracycline- and ...... by advanced myxofibrosarcoma.

@en

P1476

Activity of anthracycline- and ...... by advanced myxofibrosarcoma.

@en

P2093

Carlo Morosi

http://www.w3.org/2001/XMLSchema#string

Elena Fumagalli

http://www.w3.org/2001/XMLSchema#string

Marta Barisella

http://www.w3.org/2001/XMLSchema#string

Roberta Sanfilippo

http://www.w3.org/2001/XMLSchema#string

Rossella Bertulli

http://www.w3.org/2001/XMLSchema#string

Salvatore Provenzano

http://www.w3.org/2001/XMLSchema#string

P2860

Nonparametric Estimation from Incomplete Observations

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

The pharmacologic basis of ifosfamide use in adult patients with advanced soft tissue sarcomas.

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.

High-dose continuous-infusion ifosfamide in advanced well-differentiated/dedifferentiated liposarcoma

High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas.

High-dose ifosfamide plus adriamycin in the treatment of adult advanced soft tissue sarcomas: is it feasible?

Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Myxoid variant of malignant fibrous histiocytoma.

Low-grade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems.

P2888

s13569-017-0082-6

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13569-017-0082-6

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alessandro Gronchi

Paolo Giovanni Casali

Angelo Paolo Dei Tos

Marco Fiore

Vittoria Colia

P577

2017-08-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091167154

http://www.w3.org/2001/XMLSchema#string

P698

28852467

http://www.w3.org/2001/XMLSchema#string

P932

5568720

http://www.w3.org/2001/XMLSchema#string